MedPath

RETROVIR (AZT)

RETROVIR (AZT)

Approved
DIN Number

01902652

Drug Class

Human

Market Date

Dec 31, 1991

Company
HC

viiv healthcare ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number01902652
AIG Number0122716001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AF01 ZIDOVUDINE
Product Specifications
Dosage FormSyrup
Route of AdministrationOral
AHFS Classification08:18.08.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

ZIDOVUDINEActive
Strength: 50 MG / 5 ML
Monograph: ZIDOVUDINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.